Chonluten (Glu-Asp-Arg) is a synthetic short peptide bioregulator specifically investigated for its epigenetic and transcriptomic interactions within respiratory and epithelial tissue models. Preclinical evaluation centers on its ability to bind nuclear chromatin, modulate gene expression, and alter cellular responses to environmental stressors in vitro. PX1 Research provides high-purity, analytical-grade Chonluten strictly formatted for laboratory research use.
Chonluten (Glu-Asp-Arg) is a synthetic short peptide bioregulator specifically investigated for its epigenetic and transcriptomic interactions within respiratory and epithelial tissue models. Preclinical evaluation centers on its ability to bind nuclear chromatin, modulate gene expression, and alter cellular responses to environmental stressors in vitro. PX1 Research provides high-purity, analytical-grade Chonluten strictly formatted for laboratory research use.
Chonluten research focuses on a synthetic short-chain peptide composed of three amino acid residues: L-glutamic acid, L-aspartic acid, and L-arginine (Glu-Asp-Arg or EDG). Categorized within the broad class of Khavinson peptide bioregulators, Chonluten was developed to model the targeted transcriptomic regulatory activity of endogenous bio-active short peptides found in respiratory tissues.
At the molecular level, Chonluten exhibits a low molecular weight (approximately 388.38 g/mol), which allows it to readily cross cellular and nuclear membranes in laboratory models without requiring complex delivery vectors. In vitro structural analyses demonstrate that the chemical arrangement of the acidic residues (glutamic acid and aspartic acid) alongside the basic side group of arginine creates a distinct electrostatic profile capable of site-specific interactions with double-stranded DNA and histone proteins.
Researchers evaluating research-grade Chonluten peptide typically investigate its chemical stability, binding affinities, and specific structural motifs. The primary objective of contemporary Chonluten research is to elucidate how small, non-coding peptide sequences alter chromatin architecture and gene expression profiles without inducing direct genomic alterations.
The primary mechanism of action characterized in Chonluten research involves direct epigenetic modulation. Preclinical studies suggest that short peptides like Glu-Asp-Arg penetrate cellular nuclei and bind to specific canonical nucleotide sequences in the promoter regions of target genes. This binding alters local DNA-histone interactions, facilitating a more relaxed euchromatin state that permits enhanced RNA polymerase access.
In vitro transcription assays demonstrate that Chonluten selective binding modulates the transcription rate of genes associated with cellular homeostasis, structural protein synthesis, and anti-apoptotic signaling pathways. Unlike conventional transcription factors that require complex signal transduction cascades, tripeptides like Chonluten appear to function via direct, ligand-DNA electrostatic matching.
In vitro data indicate that this selective binding alters the synthesis of key structural components in pulmonary tissue cultures, including surfactant proteins and cytokeratins. Researchers utilizing the PX1 peptide research library analyze these mechanisms to understand the broader implications of short peptide signaling in cellular differentiation and repair assays.
In vitro research using bronchial epithelial cell lines and primary lung tissue cultures has highlighted the cellular activity of Chonluten under both basal and stressed conditions. Experimental designs often expose pulmonary cell cultures to toxic stimuli—such as cigarette smoke extract, industrial particulate matter, or oxidative agents—to evaluate the peptide's protective and restorative potential at the cellular level.
Preclinical rodent models focused on pulmonary injury indicate that administration of Glu-Asp-Arg correlates with reduced markers of inflammatory signaling, including lower local concentrations of pro-inflammatory cytokines such as TNF-alpha and IL-6. Concurrently, researchers observe a restoration of normal alveolar architecture and reduced collagen deposition in fibrotic models.
Furthermore, tissue explant assays demonstrate that Chonluten application increases the mitotic index of bronchial epithelial cells without inducing hyperplastic or neoplastic changes. These observations make the compound a frequent subject of study in cellular senescence, tissue engineering, and pulmonary pathology research frameworks.
Chonluten operates within a broader family of synthetic tri- and tetra-peptide bioregulators designed to mimic tissue-specific signaling pathways. To fully understand its niche in peptide research, investigators frequently compare its activity against structurally analogous compounds targeted at different organ systems.
For example, while Chonluten (Glu-Asp-Arg) demonstrates high specificity for bronchial and epithelial cell lines, Bronchogen research examines a tetrapeptide variant (Ala-Glu-Asp-Leu) that acts on similar pulmonary markers through slightly different gene target profiles. Similarly, Vesugen tripeptide studies evaluate Lys-Glu-Asp for its selective effects on vascular endothelial cells, whereas Thymogen immunomodulatory peptide assays investigate Glu-Trp interactions within lymphatic and immune cells.
In comparative chromatin-binding assays, each short peptide exhibits distinct nucleotide sequence preference, underscoring the high specificity of peptide bioregulation despite minimal primary structural length. Researchers often catalog these comparative profiles across our comprehensive catalog of synthetic bioregulatory peptides to design multi-target cell culture protocols.
A major domain of Chonluten research involves evaluating cellular resilience under hypoxic and oxidative conditions. Hypoxia-inducible factor 1-alpha (HIF-1a) signaling pathways are central to how pulmonary cells survive low-oxygen environments, such as those encountered in acute respiratory distress cellular models.
In vitro data indicate that pre-incubation of lung fibroblasts and epithelial cells with Glu-Asp-Arg stabilizes mitochondrial membrane potential during induced oxidative stress. This stabilization correlates with decreased intracellular reactive oxygen species (ROS) accumulation and lower rates of stress-induced apoptotic cell death.
Cellular assays also reveal that Chonluten upregulates endogenous antioxidant enzyme pathways, specifically superoxide dismutase (SOD) and catalase expression. By modulating these protective transcriptomic pathways, the peptide provides a useful reagent model for studying tissue survival mechanisms in ischemic or hypoxic culture conditions.
To ensure reproducible experimental results, laboratory researchers must follow strict protocols for reconstituting and storing lyophilized Chonluten. The peptide is typically supplied as a sterile, lyophilized white powder containing pure Glu-Asp-Arg acetate salt.
For reconstituted working solutions, standard laboratory practice involves using sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile Phosphate-Buffered Saline (PBS, pH 7.4), depending on the requirements of the downstream assay. When conducting cell culture studies sensitive to preservative agents, sterile non-preserved 0.9% Sodium Chloride or standard culture medium should be utilized immediately prior to application.
Lyophilized Chonluten remains stable at -20°C for up to 24 months. Once reconstituted, stock solutions should be aliquoted into single-use polypropylene tubes to prevent repeated freeze-thaw cycles and stored at -80°C for extended stability or 4°C for short-term use (under 7 days). Complete handling protocols and solubilization parameters can be reviewed in the laboratory guidance documentation at PX1 Research.
Experimental reproducibility in peptide research depends entirely on the chemical purity and precise quantification of the target compound. Impurities, residual solvents, or truncated peptide sequences can introduce unquantified variables into cell culture assays, confounding research outcomes.
PX1 Research enforces stringent quality assurance standards for every lot of Chonluten. Verification requires dual analytical testing:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm peptide purity exceeds 98.0%, ensuring the absence of deletion sequences or synthetic side-products. 2. Liquid Chromatography-Mass Spectrometry (LC-MS) to verify precise molecular weight and identity matching the Glu-Asp-Arg theoretical chemical structure.
Additionally, because Chonluten is frequently deployed in sensitive cell culture models, endotoxin testing (LAL assay) is conducted to ensure levels remain strictly below <0.01 EU/mg. Every batch is manufactured in GMP-compliant facilities within the USA and verified by an independent ISO 17025 accredited testing laboratory.
Procuring research reagents requires complete transparency regarding chemical origin, manufacturing standards, and batch consistency. Academic institutions, biotechnology firms, and contract research organizations (CROs) require detailed documentation to satisfy institutional review and assay validation requirements.
PX1 Research provides a lot-specific Certificate of Analysis (COA) with every shipment of Chonluten. Each COA provides raw HPLC chromatograms, mass spectra, moisture content analysis, and certified endotoxin measurements. Orders are processed with same-day shipping (Monday through Friday) originating directly from centralized US fulfillment centers in California and Arizona.
For institutions conducting high-volume screening or multi-phase experimental series, PX1 offers streamlined bulk laboratory research supply options to ensure long-term lot consistency across multi-year research projects.
Research into Chonluten and related short peptide bioregulators represents a growing frontier in epigenetic and structural biochemistry. As molecular biology tools evolve, investigators are increasingly leveraging single-cell RNA sequencing (scRNA-seq) and high-throughput transcriptomics to map the exact genomic footprint of Glu-Asp-Arg across diverse tissue types.
Emerging areas of investigation include assessing whether short peptides can act synergistically in co-culture models, evaluating peptide-nanoparticle delivery systems for controlled lab administration, and exploring chromatin remodeling mechanisms during cellular aging.
PX1 Research remains committed to supporting advanced peptide research by delivering ultra-pure, USA-manufactured reagents designed strictly for laboratory and in vitro exploration.
What is Chonluten in laboratory research?
Chonluten is a synthetic tripeptide bioregulator composed of L-glutamic acid, L-aspartic acid, and L-arginine (Glu-Asp-Arg). In laboratory research, it is investigated for its interactions with nuclear chromatin, gene expression modulation, and tissue-specific protective mechanisms in respiratory cell models.
What is the primary mechanism of action studied for Chonluten?
Preclinical studies indicate that Chonluten acts through direct epigenetic modulation. It penetrates cell nuclei, binds specific regions of DNA and histone proteins, and alters gene transcription rates associated with cell survival, structural protein expression, and stress responses.
How does Chonluten compare to Bronchogen in research applications?
While both peptides are studied for their effects on pulmonary and epithelial cell lines, Chonluten is a tripeptide (Glu-Asp-Arg) and Bronchogen is a tetrapeptide (Ala-Glu-Asp-Leu). They exhibit distinct DNA-binding profiles and target different transcriptomic pathways in vitro.
What solvent should be used to reconstitute Chonluten for cell culture assays?
For in vitro cell culture studies where preservatives could alter cell viability, sterile Phosphate-Buffered Saline (PBS, pH 7.4) or sterile non-preserved 0.9% NaCl is typically recommended. For general laboratory storage stability, sterile Bacteriostatic Water can be used.
How is the purity of PX1 Research Chonluten verified?
PX1 Research verifies every lot of Chonluten using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm >98% chemical purity and Liquid Chromatography-Mass Spectrometry (LC-MS) to verify exact identity and molecular weight. Testing is performed by independent ISO 17025 accredited laboratories.
What are the recommended laboratory storage conditions for Chonluten?
Lyophilized Chonluten powder should be stored at -20°C in a dry, dark environment. Once reconstituted into liquid solution, stock aliquots should be stored at -80°C for long-term preservation to avoid degradation from repeated freeze-thaw cycles.
Are PX1 Research peptides compliant with endotoxin limits for cell assays?
Yes. Every batch of Chonluten undergoes Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below <0.01 EU/mg, preventing unwanted immune or inflammatory artifact responses in sensitive cellular assays.
Is Chonluten approved for human consumption or therapeutic use?
No. Chonluten supplied by PX1 Research is strictly designated for laboratory research use only (in vitro and preclinical study). It is not for human or animal consumption, medical treatment, or clinical administration.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.